IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,537,000 | +1751.8% | 40,041 | +820.7% | 0.00% | – |
| Q2 2023 | $83,000 | +38.3% | 4,349 | +12.1% | 0.00% | – |
| Q1 2023 | $60,000 | -45.0% | 3,879 | -37.2% | 0.00% | – |
| Q4 2022 | $109,000 | +1111.1% | 6,176 | +300.8% | 0.00% | – |
| Q3 2022 | $9,000 | +80.0% | 1,541 | +21.7% | 0.00% | – |
| Q2 2022 | $5,000 | -75.0% | 1,266 | -64.2% | 0.00% | – |
| Q1 2022 | $20,000 | -73.0% | 3,533 | -59.0% | 0.00% | – |
| Q4 2021 | $74,000 | +94.7% | 8,626 | +96.1% | 0.00% | – |
| Q3 2021 | $38,000 | +15.2% | 4,398 | +41.5% | 0.00% | – |
| Q2 2021 | $33,000 | -13.2% | 3,109 | +32.2% | 0.00% | – |
| Q1 2021 | $38,000 | -59.6% | 2,351 | +15.5% | 0.00% | – |
| Q4 2020 | $94,000 | +56.7% | 2,035 | +20.3% | 0.00% | – |
| Q3 2020 | $60,000 | +5900.0% | 1,691 | +3926.2% | 0.00% | – |
| Q2 2020 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |